Cargando…
Treatment of alcoholic hepatitis: is this a “dead-end”?
Autores principales: | Akriviadis, Evangelos, Sinakos, Emmanouil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805751/ https://www.ncbi.nlm.nih.gov/pubmed/27065743 http://dx.doi.org/10.20524/aog.2016.0023 |
Ejemplares similares
-
Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients
por: Papachrysos, Nikolaos, et al.
Publicado: (2015) -
Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature
por: Kalogirou, Maria, et al.
Publicado: (2018) -
The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence
por: Sinakos, Emmanouil, et al.
Publicado: (2011) -
COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
por: Lundstrom, Kenneth, et al.
Publicado: (2021) -
Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels
por: Sinakos, Emmanouil, et al.
Publicado: (2016)